Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2010-07-13
Original market date: See footnote 1
1996-12-04
Product name:
CLONAZEPAM-0.5 - TAB 0.5MG
DIN:
02220598 Electronic product monograph is not available
Company:
PRO DOC LIMITEE
2925 Boulevard Industriel
Laval
Quebec
Canada
H7L 3W9
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Targeted (CDSA IV)
American Hospital Formulary Service (AHFS): See footnote 3
28:12.08
Anatomical Therapeutic Chemical (ATC): See footnote 4
N03AE01 CLONAZEPAM
Active ingredient group (AIG) number:See footnote5
0111558001
Active ingredient(s) | Strength |
---|---|
CLONAZEPAM | .5 MG |